These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


157 related items for PubMed ID: 2140846

  • 1. Hormonal responses to fenfluramine in depressed and control subjects.
    Mitchell P, Smythe G.
    J Affect Disord; 1990 May; 19(1):43-51. PubMed ID: 2140846
    [Abstract] [Full Text] [Related]

  • 2. Hormone responses to fenfluramine and placebo challenge in endogenous depression.
    Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B.
    Psychiatry Res; 1992 Aug; 43(2):137-46. PubMed ID: 1410069
    [Abstract] [Full Text] [Related]

  • 3. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P, Smythe G, Parker G, Wilhelm K, Hickie I, Brodaty H, Boyce P.
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [Abstract] [Full Text] [Related]

  • 4. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
    O'Keane V, Dinan TG.
    Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
    [Abstract] [Full Text] [Related]

  • 5. Cortisol, ACTH, prolactin and beta-endorphin responses to fenfluramine administration in major-depressed patients.
    Maes M, Jacobs MP, Suy E, Minner B, Raus J.
    Neuropsychobiology; 1989 Aug; 21(4):192-6. PubMed ID: 2561010
    [Abstract] [Full Text] [Related]

  • 6. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
    Lerer B, Gillon D, Lichtenberg P, Gorfine M, Gelfin Y, Shapira B.
    Int Psychogeriatr; 1996 Aug; 8(1):83-102. PubMed ID: 8805090
    [Abstract] [Full Text] [Related]

  • 7. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects.
    Cleare AJ, Murray RM, O'Keane V.
    Neuropsychopharmacology; 1996 May; 14(5):349-54. PubMed ID: 8703303
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone and other hormonal responses to clonidine in melancholic and nonmelancholic depressed subjects and controls.
    Mitchell P, Smythe G, Parker G, Wilhelm K, Brodaty H, Boyce P, Hickie I.
    Psychiatry Res; 1991 May; 37(2):179-93. PubMed ID: 1652141
    [Abstract] [Full Text] [Related]

  • 9. d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.
    Thakore JH, O'Keane V, Dinan TG.
    Am J Psychiatry; 1996 Nov; 153(11):1460-3. PubMed ID: 8890681
    [Abstract] [Full Text] [Related]

  • 10. Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression.
    Shapira B, Yagmur MJ, Gropp C, Newman M, Lerer B.
    Biol Psychiatry; 1992 May 15; 31(10):975-83. PubMed ID: 1511080
    [Abstract] [Full Text] [Related]

  • 11. Cholesterol and serotonin indices in depressed and suicidal patients.
    Sarchiapone M, Camardese G, Roy A, Della Casa S, Satta MA, Gonzalez B, Berman J, De Risio S.
    J Affect Disord; 2001 Feb 15; 62(3):217-9. PubMed ID: 11223109
    [Abstract] [Full Text] [Related]

  • 12. Prolactin and cortisol responses to fenfluramine challenge in mania.
    Yatham LN.
    Biol Psychiatry; 1996 Feb 15; 39(4):285-8. PubMed ID: 8645775
    [Abstract] [Full Text] [Related]

  • 13. Plasma cortisol, prolactin, growth hormone, and immunoreactive beta-endorphin response to fenfluramine challenge in depressed patients.
    Weizman A, Mark M, Gil-Ad I, Tyano S, Laron Z.
    Clin Neuropharmacol; 1988 Jun 15; 11(3):250-6. PubMed ID: 2969772
    [Abstract] [Full Text] [Related]

  • 14. Depression in premenopausal women: gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test.
    Rajewska J, Rybakowski JK.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun 15; 27(4):705-9. PubMed ID: 12787860
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.
    Abel KM, O'Keane V, Murray RM.
    Br J Psychiatry; 1996 Jan 15; 168(1):57-60. PubMed ID: 8770429
    [Abstract] [Full Text] [Related]

  • 16. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV, O'Keane V, Butcher G, Clare AW, Dinan TG.
    Br J Psychiatry; 1992 Oct 15; 161():517-21. PubMed ID: 1393339
    [Abstract] [Full Text] [Related]

  • 17. Fenfluramine provocation of anxiety in patients with panic disorder.
    Targum SD, Marshall LE.
    Psychiatry Res; 1989 Jun 15; 28(3):295-306. PubMed ID: 2669003
    [Abstract] [Full Text] [Related]

  • 18. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls.
    Ramasubbu R, Flint A, Brown G, Awad G, Kennedy S.
    J Affect Disord; 1999 Jun 15; 52(1-3):121-33. PubMed ID: 10357025
    [Abstract] [Full Text] [Related]

  • 19. D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment.
    O'Keane V, McLoughlin D, Dinan TG.
    J Affect Disord; 1992 Nov 15; 26(3):143-50. PubMed ID: 1460163
    [Abstract] [Full Text] [Related]

  • 20. Abnormal serotonergic control of prolactin and cortisol secretion in patients with seasonal affective disorder.
    Coiro V, Volpi R, Marchesi C, De Ferri A, Davoli C, Caffarra P, Rossi G, Caffarri G, Davolio M, Chiodera P.
    Psychoneuroendocrinology; 1993 Nov 15; 18(8):551-6. PubMed ID: 8127946
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.